IBRX
Immunitybio
$6.99
−$0.11 (−1.55%)Jul 27, 2026
Key metrics
The numbers that frame IBRX today
- Market cap
- $7.32B
- P/E (TTM)
- -8.6
- EV / FCF
- -27.5
- Gross margin
- 99.3%
- EV / Sales
- 58.4
- ROIC
- -60%
- Div yield
- 0%
- 52wk Low
- $1.95
- 52wk High
- $12.43
Growth
Revenue and earnings trend for IBRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IBRX
Is Immunitybio a good buy?
Hold. Immunitybio has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Immunitybio is selling at a high price.
What is the market capitalization of IBRX?
Immunitybio's market capitalization is $7.32B.
What is the P/E ratio for IBRX stock?
Immunitybio's current P/E ratio is -8.6.
What is the 52-week high for IBRX stock?
The 52-week high for Immunitybio is $12.43. The current close of $6.99 is 43.8% below that high.
What is the 52-week low for IBRX stock?
The 52-week low for Immunitybio is $1.95. The current close of $6.99 is 258.5% above that low.
Does IBRX stock pay dividends?
Immunitybio does not currently show a dividend per share in the company data.